Specialty: Mental Health, Primary sub-specialty: Personality Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 or over 2. Clinical diagnosis of personality disorder 3. Positive screening result using the International Personality Disorder Examination self-administered questionnaire 4. Competent and willing to provide written, informed consent
Exclusion criteria
Exclusion criteria: 1. A current clinical diagnosis of a co-existing organic or psychotic mental disorder (dementia, bipolar affective disorder (type I and II), delusional disorder, schizophrenia, schizoaffective disorder or schizotypal disorder 2. Cognitive or language difficulties that would preclude subjects providing informed consent or compromise participation in study procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility of the study is measured using the following: 1. Recruitment of at least 80% of the study sample i.e 48 participants from the total of 60 we are aiming to recruit. 2. Uptake of the low intensity intervention by at least 60% of participants in the active arm of the trial i.e. 18 of the 30 who are randomised to the low intensity intervention will have received it according to feedback from the therapist assigned to the participant. 3. Completion of follow-up interviews at six months by 75% of study participants. To determine the feasibility of calculating a cost analysis of health economics, we will record completion rates for the cost data, and analyse them to determine what the cost-drivers are likely to be if proceeding to a full clinical trial. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Impairment of functioning is measured using the Work and Social Adjustment Scale at baseline and six months 2. Mental health is assessed using the participant-completed Warwick and Edinburgh Well-Being Schedule at baseline and six months 3. Suicidal thoughts and behaviour is measured using Four questions on suicidal thoughts and behaviour taken from the national household survey of psychiatric morbidity at baseline and six months 4. Health-related quality of life is measured using the EuroQol Five Dimensions (EQ-5D) at baseline and six months 5. Satisfaction with care is assessed using the participant-completed four-item Client Satisfaction Questionnaire at baseline and six months 6. Resource use and costs are assessed using a modified version of the Adult Service User Schedule (AD-SUS) at baseline and six months 7. Change in overall health is measured using the patient version of the Clinical Global Impression Scale at baseline and six months | — |
Countries
United Kingdom